Leadership

Our innovative approach and unwavering commitment to scientific excellence combines polymers chemistry, immunology and artificial intelligence.

arrow

Shira Orr, PhD.

  • Shira is a pioneering force in the domain of drug delivery systems. She has been developing biopolymers for 25 years starting in the Israeli Technology Intelligence unit at the age of 18. Following her military service Shira completed her BSc. And MSc. cum laude at Tel Aviv University. Throughout her Ph.D. studies she received the distinguished Kraitman excellence scholarship, followed by a postdoc at Harvard Medical School. Following her postdoctoral work, Shira has gained experience in the pharma industry. Shira believes that bio-polymer based nanoparticles delivery system is the answer to gene therapy and will reshape the boundaries of drug delivery and patient care.

arrow

Trinayan Kashyap

  • Trinayan brings over 13 years of extensive expertise in the entire drug development process, spanning from discovery through clinical development of small molecules and tRNA-based therapies targeting both oncology and non-oncology indications. Before joining the Envoya team, Trinayan served as the Executive Director of Research at hC Biosciences, where he successfully led proof-of-concept studies for an innovative engineered tRNA. His career includes an 11-year tenure at Karyopharm Therapeutics, where he played pivotal roles in the bench-to-bedside development of Xpovio (selinexor), the first-in-class selective inhibitor of nuclear export (SINE) compound, targeting various hematological malignancies. Trinayan led successfully translational research efforts, encompassing biomarker initiatives, to validate clinical trial findings. Trinayan has demonstrated proficiency in leading alliance collaborations, managing regulatory submissions, and overseeing global CROs. His contributions extend to the publication of numerous manuscripts resulting from his research endeavors, as well as holding patents related to nuclear transport modulators.

    He earned his MS in Biology from the University of Massachusetts, Lowell, and is currently pursuing an MBA from the Isenberg School of Management at the University of Massachusetts, Amherst.

Ori Shaashua

  • Ori is an AI luminary that has been at the forefront of artificial intelligence advancements since 2013. His entrepreneurial acumen is evident through his founding of numerous pioneering companies, one of which played a crucial role in helping national governments accurately forecast COVID-19 transmission rates. Beyond his technical prowess, Ori’s well-rounded leadership style is characterized by a blend of strategic business thinking and innate ability to inspire those around him. Consistently pushing boundaries, Ori achieves what many consider impossible, solidifying his reputation not only as a tech innovator but also as a visionary leader.

Eran Orr

  • Eran boasts a multifaceted background that spans from the skies to the boardroom. Serving as an F-16 pilot for 15 years in the IDF, his dedication and precision are traits that have seamlessly transitioned into his entrepreneurial endeavors. His tenacious leadership style, characterized by vision and resilience, has been instrumental in steering his companies towards growth and prosperity. A proud graduate of Harvard’s Global Health Leadership Program, Eran has established himself as a seasoned healthcare entrepreneur. With a portfolio of 5 approved patents, his innovative spirit is undeniable. As the founder of XRHealth he further showcases his dedication to transforming healthcare. Under Eran’s guidance, his ventures don’t just flourish; they bloom, marking a legacy of sustained growth and impactful contributions.

Alysa Langburt

  • Alysa has 17 years of clinical research expertise and a distinguished academic foundation including a recent alumna of the Global Health Leadership Program at Harvard Medical School. Over the last decade, she played an instrumental role in establishing the largest fully owned research site network in North America. With an astute business mind, Alysa’s capability in forging strategic partnerships has paved the network’s success and growth. Her unique ability to simplify complex challenges into actionable solutions marks a leadership style rooted in role modeling, setting standards of excellence that push teams to realize and harness their full potential, leading them towards unprecedented achievements.

Leading Advisory Board

Stephen Chang, Ph.D.

UC Irvine
PhD, Biochemical Genetics
Board Member at Mirimus
Biotechnology industry leading expert

_____

Avi Rosenbaum, Ph.D.

Harvard University, Advisors.bio
Ph.D. in Genetics
Industry leading expert advisor in biotechnology for investors, startups, and mature companies.

Raphael Nir, Ph.D.

SBH Sciences, Abi Lab
Ph.D. in Biotechnology
Founder and CEO, SBH

_____